Drugs Made In America Acquisition Corp.

HEIGHTS CAPITAL MANAGEMENT, INC DMAA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

650,000

Value ($000)

6,741

Weight

2.6%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	6,741	2.6%	650,000	12/31/2025
2025 Q3	11/18/2025	6,676	2.1%	650,000	9/30/2025
2025 Q2	8/14/2025	6,630	2.1%	650,000	6/30/2025